AcuityBio and Cook Biotech Announce Agreements for Strategic Collaboration and Development of AcuityBio's ABC103
September 05, 2018
September 05, 2018
WEST LAFAYETTE, Indiana, Sept. 5 -- Purdue University issued the following news release:
AcuityBio Inc., a developer of novel drug-delivery, combination products, announced Wednesday (Sept. 5) that it has entered into agreements with Cook Biotech Inc., a leader in advanced biomaterials and regenerative medicine.
Under the terms of the agreements, both companies will collaborate in the advancement of AcuityBio's ABC103 lead product for lung cancer, which will utilize Co . . .
AcuityBio Inc., a developer of novel drug-delivery, combination products, announced Wednesday (Sept. 5) that it has entered into agreements with Cook Biotech Inc., a leader in advanced biomaterials and regenerative medicine.
Under the terms of the agreements, both companies will collaborate in the advancement of AcuityBio's ABC103 lead product for lung cancer, which will utilize Co . . .